Briglau

Medicinal product

(Invented) name

Briglau

Active substance (s)

Brimonidino tartratas

Strength

2 mg/ml

Pharmaceutical form

akių lašai (tirpalas)

Route (s) of administration

vartoti ant akių

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01EA05, Brimonidine

Marketing authorisation holder

Medana Pharma SA, Lenkija

Date of authorisation

2012-12-17

Date of renewal

2018-05-29

Documents

3153_1 Pakuotės lapelis 181030.docx

3153_1 Briglau_PZ PL 181030.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

NL/H/2433/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Brimonidino tartratas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47566	61386	1061386	buteliukas	5 ml N1		Receptinis	LT/1/12/3153/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-12-05	Išregistruotas
2018-05-29	Perregistruotas
2012-12-17	Registruotas